Open AccessP605: T‐CELL PROLYMPHOCYTIC LEUKEMIA: MOLECULAR CHARACTERIZATION OF A COHORT OF 18 PATIENTS AND EVALUATION OF BORTEZOMIB AS A POSSIBLE THERAPEUTIC STRATEGY
Author(s) -
Gasparini V. R.,
Martines A.,
Barilà G.,
Teramo A.,
Calabretto G.,
Vicenzetto C.,
Carraro S.,
Trimarco V.,
Trentin L.,
Facco M.,
Semenzato G.,
Bonaldi L.,
Zambello R.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845308.89529.b0
Subject(s) - prolymphocytic leukemia , bortezomib , medicine , cancer research , fludarabine , immunology , oncology , leukemia , multiple myeloma , chronic lymphocytic leukemia , chemotherapy , cyclophosphamide